EUVIMEDEUVIMED entdecken
Crossref

Isoxazole and Pyrazole Derivatives of 28‐Oxo‐Allobetulone Target Viral Membrane Glycoprotein Hemagglutinin

Irina E Smirnova, Alexandrina S Volobueva, Iana L Esaulkova, Sergei B Fedij, Vladimir V Zarubaev, Oxana B Kazakova iD

Chemical Biology & Drug Design · 2025

DOI: 10.1111/cbdd.70099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2025. Verfasst von Irina E Smirnova und 5 weiteren Autor:innen. Beteiligte Einrichtung: Ufa Federal Research Center, Russian Academy of Sciences, Ufa Institute of Chemistry, Ufa, Russian Federation. Hauptthemen laut MEDLINE: Pyrazoles, Antiviral Agents, Influenza A Virus, H1N1 Subtype, Isoxazoles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of [2,3]‐isoxazoles and pyrazole annulated with the A‐ring of lupane, oleanane, and ursane type triterpenoids was synthesized and screened for antiviral activity. It was found that 28‐oxo‐allobetulone isoxazole 4 with IC 50 7.3 μM (SI 86) and pyrazole 5 with IC 50 62.1 μM (SI 10) demonstrated a high inhibitory activity against Flu A/Puerto Rico/8/34 (H1N1) strain virus. The compounds 4 and 5 appeared to be the most active at the earlier stages of the viral cycle (0–2 h post infecting). No inhibiting effect of compounds 4 and 5 on the fusogenic activity of hemagglutinin HA has been detected, but the compounds prevented the binding of virions with the cell receptor. According to the results of molecular docking, compounds 4 and 5 preferentially bound to the interface between HA1 and HA2 subunits of hemagglutinin, near the heptad repeat domain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrazolesAntiviral AgentsInfluenza A Virus, H1N1 SubtypeIsoxazolesHemagglutinin Glycoproteins, Influenza VirusMolecular Docking SimulationAnimalsHumansDogsMadin Darby Canine Kidney Cells

Stichwörter der Autor:innen

H3N2H5N2allobetulinanti‐influenza activityflu a H1N1hemagglutininisoxazolemolecular dockingpentacyclic triterpenoidspyrazole

Substanzen

PyrazolesAntiviral AgentsIsoxazolesHemagglutinin Glycoproteins, Influenza Virus

Autor:innen und Institutionen

  • Ufa Federal Research Center, Russian Academy of Sciences, Ufa Institute of Chemistry, Ufa, Russian Federation.
  • Department of Virology, St. Petersburg Pasteur Institute of Epidemiology and Microbiology, St. Petersburg, Russian Federation.
  • Biology Department, St. Petersburg State University, St. Petersburg, Russian Federation.

ORCID-Profile: Oxana B Kazakova

Zitieren

APA

Smirnova, I. E., Volobueva, A. S., Esaulkova, I. L., Fedij, S. B., Zarubaev, V. V., & Kazakova, O. B. (2025). Isoxazole and Pyrazole Derivatives of 28‐Oxo‐Allobetulone Target Viral Membrane Glycoprotein Hemagglutinin. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70099

Vancouver

Smirnova IE, Volobueva AS, Esaulkova IL, Fedij SB, Zarubaev VV, Kazakova OB. Isoxazole and Pyrazole Derivatives of 28‐Oxo‐Allobetulone Target Viral Membrane Glycoprotein Hemagglutinin. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70099

BibTeX
@article{Smirnova2025,
  author = {Smirnova, Irina E and Volobueva, Alexandrina S and Esaulkova, Iana L and Fedij, Sergei B and Zarubaev, Vladimir V and Kazakova, Oxana B},
  title = {Isoxazole and Pyrazole Derivatives of 28‐Oxo‐Allobetulone Target Viral Membrane Glycoprotein Hemagglutinin},
  journal = {Chemical Biology & Drug Design},
  year = {2025},
  doi = {10.1111/cbdd.70099}
}
Kostenlos starten →